Tipik/Atipik Antipsikotik İlaç Zehirlenmeleri

Boushra M, Nagalli S. Neuroleptic Agent Toxicity. [Updated 2020 Nov 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.

Balta M, İkizceli İ. Antipsikotikler: Klinik toksikoloji tanı ve tedavi. Ed: Satar S et al. 2020; 74: 528-40

Ingrid B, Nicholas A B, Geoffrey K I. The antipsicotic story: changes in prescriptions and overdose without better safety. Br J Clin Pharmacol. 2016 Jul; 82(1): 249-54.

Michael L, Frank LV. Antipsychotics. In Judith E. Tintinally, MD, MS Editor. Emergency Medicine. 8th ed. 2016; 1128-32

Aaron BS, Jessica M. Rosen’s Emergency Medicine Consepts and Clinical Practice, 9th edition, Ed: Ron MW et al. 2018;1937-42

Levine M, Lovecchio F, Tafoya P, et al: Paliperidone overdose with delayed onset of toxicity. Ann Emerg Med. 2011; 58(1):80–82.

Levine M, Ruha AM: Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management. CNS Drugs. 2012; 26 (7): 601–611.

Öztürk M O, Uluşahin Ö. Ruh sağlığı ve bozuklukları: Ruhsal bozukluklarda ilaç sağaltımı. 15. Baskı, 2018; 28:659-72

van Harten P N, Tenback D E, Tardive dyskinesia: Clinical presentation and treatment . Int Rev Neurobiol, 2011; 98: 187-210.

Tural U, Onder E. Clinical and pharmacologic risk factors for neuroleptic malingnant syndrome and their association with death. Psychiatry Clin Neurosci, 2010; 64 (1): 79-87.

Nielsen J et al. Assessing QT interval prolongation and its associated risks with antipsyhotics, CNS drugs, 2011; 25: 473-90.

De Berrardis et al. Update on the adverse effects of clozapine: focus on miyocarditis. Curr Drug Saf. 2012; 7: 55-62

Bülbül N G, Seçil Y, Beckmann Y et al. Nörolojik yoğun bakım izlemi gerektiren nöroleptik malign sendrom: dokuz olgu ile gözden geçirme, Türk yoğun bakım derneği dergisi. 2014; 12: 110-7

Dominic J P, Aaron M C. Neuroleptic malignant syndrome review: Focus on treatment and rechallenge, Annals of pharmacotherapy. 2016; 1-9.

Tse L, Barr AM, Scarapicchia V et al. Neuroleptic malignant syndrome: a review from a clinically oriented perspective. Curr Neuropharmacol. 2015; 13: 395-406.

Panagariya A, Sharma B, Singh R et al. The neuroleptic malignant syndrome: a report of 14 cases from north India. Neurol India. 2007; 55: 166-168.